Colonoscopic surveillance for cancer in ulcerative colitis: A critical review

Journal of Pediatric Gastroenterology and Nutrition

Volumn 24, Issue 2, 1997, Pages 202-210

  Griffiths, Anne M ^a   Sherman, Philip M ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; HUMAN; PRIORITY JOURNAL; RELIABILITY; REVIEW; RISK FACTOR; ULCERATIVE COLITIS;

COHORT STUDIES; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; COLONOSCOPY; CROSS-SECTIONAL STUDIES; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0030896409     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199702000-00015     Document Type: Review

References (52)

1. Ekbom A, Helmick C, Zack M, Adami H-O. Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med 1990; 323:1228-33.
2. Brostrom O, Lofberg R, Nordenvall B, Ost A, Hellers G. The risk of colorectal cancer in ulcerative colitis: an epidemiologic study. Scand J Gastroenterol 1987;22:1193-9.
3. Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988;29:206-17.
4. Gilat T, Fireman Z, Grossman A, et al. Colerectal cancer in patients with ulcerative colitis: a population study central Israel. Gastroenterology 1988;94:870-7.
5. Katzka I, Brody RS, Morris E, Katz S. Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice. Gastroenterology 1983;85:22-9.
6. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990;31:800-6.
7. Levin B, Lennard-Jones J, Riddell RH, Sachar D, Winawer SJ. Surveillance of patients with chronic ulcerative colitis: WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull WHO 1991;69:121-6.
8. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44.
9. Lynch DAF, Lobo AJ, Sobala GM, Dixon MF, Axon ATR. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993;34: 1075-80.
10. Rosenstock E, Farmer RG, Petras R, Sivak MV Jr, Rankin GB, Sullivan BH. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985;89:1342-6.
11. Lofberg R, Brostrom O, Per K, Tribukait B, Ost A. Colonoscopic surveillance in long-standing total ulcerative colitis - a 15 year follow-up study. Gastroenterology 1990;99:1021-31.
12. Nugent FW, Haggitt RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology 1991;100:1241-8.
13. Blackstone MO, Riddell RH, Rogers BHG, Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981;80:355-74.
14. Lashner BA, Silverstein MC, Hanauer SB. Hazard rates for dysplasia and cancer in ulcerative colitis: results from a surveillance program for cancer in ulcerative colitis. Dig Dis Sci 1989;34:1536-41.
15. Leidenius M, Killokumpu I, Husa A, Riitula M, Sipparen P. Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme. Gut 1991;32: 1521-5.
16. Woolrich AJ, daSilva MD, Korelitz BI. Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology 1992;103:431-8.
17. Jonsson B, Ahsgren L, Andrsson LO, Stenling R, Rutegard J. Colorectal cancer surveillance in patients with ulcerative colitis. Br J Surg 1994;81:689-91.
18. Biasco G, Brandi G, Paganelli GM, et al. Colorectal cancer in patients with ulcerative colitis: a prospective cohort study in Italy. Cancer 1995;75:2045-50.
19. Rozen P, Baratz M, Fefer F, Gilat T. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology 1995;108:1361-70.
20. Fuson JA, Farmer RG, Hawk WA, Sullivan BH. Endoscopic surveillance for cancer in chronic ulcerative colitis. Am J Gastroenterol 1980;73:120-6.
21. Canadian Task Force on the Periodic Health Examination. Report of the task force on the periodic health examination. Can Med Assoc J 1979;121:1193-254.
22. Canadian Task Force on the Periodic Health Examination: The periodic health examination. Can Med Assoc J 1986;134:721-9.
23. Greenstein AJ, Sachar DB, Smith H, et al. Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology 1979;77:290-4.
24. Sackett DL, Whelan G. Cancer risk in ulcerative colitis: scientific requirements for the study of prognosis. Gastroenterology 1980; 78:1632-5.
25. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992;103:1444-51.
26. Sugita A, Greenstein AJ, Ribeiro MB, et al. Survival with colorectal cancer in ulcerative colitis. Ann Surg 1993;218:189-95.
27. Lavery JC, Chivilli RA, Jagelman DB. Survival with carcinoma arising in mucosal ulcerative colitis. Ann Surg 1982;195:508-12.
28. Gyde SN, Prior P, Thompson H, Waterhouse JAH, Allan RN. Survival of patients with colorectal cancer complicating ulcerative colitis. Gut 1984;25:228-31.
29. Choi PM, Nugent FW, Schoetz DJ Jr, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993;105:418-24.
30. Connell WR, Ralbot IC, Harpaz N, et al. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 1994;35:1419-23.
31. Kvist N, Jacobsen O, Kvist HK, et al. Malignancy in ulcerative colitis. Scand J Gastroenterol 1989;24:497-506.
32. Sugita A, Sachar DB, Bodian C, Ribeiro MB, Aufses AH Jr, Greenstein AJ. Colorectal cancer in ulcerative colitis: influence of anatomical extent and age at onset of colitis-cancer interval. Gut 1991;32:167-9.
33. Ahsgren L, Jonsson B, Stenling R, Rutegard J. Prognosis after early onset of ulcerative colitis: a study from an unselected patient population. Hepatogastroenterology 1993;40:467-70.
34. Cole P, Morrison AS. Basic issues in population screening for cancer. J Natl Cancer Inst 1980;5:1263-72.
35. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1988;14:931-85.
36. Dixon MF, Brown LTR, Gilmour HM. Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology 1988; 95:668-75.
37. Melville DM, Jass JR, Shepherd NA. Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis: observer variation and correlations. Gastroenterology 1988;95:668-75.
38. Ransohoff DF, Riddell RH, Levin B. Ulcerative colitis and colonic cancer: problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum 1985;261:383-8.
39. Taylor BA, Pemberton JH, Carpenter HA, et al. Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis Colon Rectum 1992;35:950-6.
40. Lashner BA. Recommendations for colorectal cancer screening in ulcerative colitis: a review of research from a single university-based surveillance program. Am J Gastroenterol 1992;87:168-75.
41. Lennard-Jones JE. Screening for colorectal cancer in ulcerative colitis [Letter]. Gut 1990;32:722-3.
42. Lashner BA, Kane SV, Hanauer SB. Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol 1990;85:1083-7.
43. Laupacis AM, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988;318:1728-33.
44. Waye J, Lewis B, Yessayan S. Colonoscopy, a prospective report of complications. Gastrointest Endosc 1990;36(suppl):A226.
45. Fruhmorgen P, Demling L. Complications of diagnostic and therapeutic colonoscopy in the Federal Republic of Germany. Endoscopy 1979;11:146-50.
46. Snith LE. Fiberoptic colonoscopy: complications of colonoscopy and polypectomy. Dis Colon Rectum 1976;19:407-12.
47. Koobatian GJ, Choi PM. Safety of surveillance colonoscopy in long-standing ulcerative colitis. Am J Gastroenterol 1994;89: 1472-5.
48. Burmer GC, Rabinovitch PS, Haggitt RC, et al. Neoplastic progression in ulcerative colitis: histology. DNA content and loss of a p53 allele. Gastroenterology 1992;103:1602-10.
49. Scott N, Quirke P. Molecular biology of colorectal neoplasia. Gut 1993;34:289-92.
50. Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611-20.
51. Lofberg R, Brostrom O, Karlen P, Ost A, Tribukait B. DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia. Gastroenterology 1992;102: 1149-54.
52. Brentnall TA, Haggitt RC, Rabinovitch PS, et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996;110: 331-8.